Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCCORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCCENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCCENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCCNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FK.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FK.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.21.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.21.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.21.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.21.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FP.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FP.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.92ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.92ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.92ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.92NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.42ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.42NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.35.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.35.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.35.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.35.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LU.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.16.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.16.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used